Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020 earnings results
Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021
Categories
Health Care
Trxade launches integrated COVID-19 risk assessment tool for corporate clients
Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such as COVID-19
Sage Therapeutics Inc (SAGE) Q2 2020 Earnings Call Transcript
Sage Therapeutics Inc (NASDAQ: SAGE) Q2 2020 earnings call dated August 10, 2020 Corporate Participants: Jeff Boyle -- Senior Director of Investor Relations Jeff
Tilray Inc. (TLRY) Q2 2020 Earnings Call Transcript
Tilray Inc. (NASDAQ: TLRY) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael
Novavax Inc. (NVAX) Q2 2020 Earnings Call Transcript
Novavax Inc (NASDAQ: NVAX) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Silvia Taylor -- Senior Vice President, Investor Relations and Corporate
Novavax (NVAX) tops Q2 2020 bottom line targets, misses revenue views
Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue jumped to
Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead
The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While these offer
Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Kevin Moran -- Vice President-Investor Relations Michael C. Kaufmann -- Chief
Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript
Zoetis Inc. (NYSE: ZTS) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Steve Frank -- Vice President of Investor Relations KristIn Peck -- Chief
Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and Public Relations
Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript
Mylan N.V. (NASDAQ: MYL) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations Heather Bresch -- Chief
Metlife Inc. (MET) Q2 2020 Earnings Conference Call Transcript
Metlife Inc. (NYSE: MET) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: John Hall -- Head of Investor Relations Michel A. Khalaf -- President
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
https://www.youtube.com/watch?v=dYv_jstT8BY&t=18s Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’
Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John
Humana Inc (HUM) Q2 2020 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q2 2020 earnings call dated August 5, 2020 Corporate Participants: Amy Smith -- Vice President of Investor Relations Bruce Broussard -- President
Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive
CVS Health Corp. (CVS) Q2 2020 Earnings Call Transcript
CVS Health Corp. (NYSE: CVS) Q2 2020 earrings call dated Aug. 05, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President of Investor
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook
Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street's revenue targets. The drug manufacturer reported adjusted EPS of
Moderna impresses on the financial side as well in Q2
Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past analysts’ estimates.
Amarin (AMRN) Q2 2020 earnings call: Focus was mainly on VASCEPA litigation
Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed mainly the
Key highlights from CVS Health (CVS) Q2 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today. Total revenues increased 3% to $65.3 billion, driven by growth